首页> 外文期刊>Nagoya journal of medical science >The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma
【24h】

The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma

机译:通过双时间点18F-氟脱氧葡萄糖正电子发射断层显像技术计算出的最大标准化摄取值增量可预测口腔鳞状细胞癌患者的存活率

获取原文
获取外文期刊封面目录资料

摘要

The aim of this study was to investigate the prognostic value of dual-time-point (DTP) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in primary oral tongue squamous cell carcinoma (OTSCC). The study included 52 patients who underwent preoperative 18F-FDG PET scans at two time points, namely 1 h and 2 h after injection. The following PET parameters were calculated: maximum standardized uptake value (SUVmax) for both time points (SUV early, SUV delayed); retention index (RI); and SUVmax increment (ΔSUVmax). Receiver operating characteristic (ROC) curve analysis was performed to define the optimal cutoff point for these parameters. Overall survival was calculated using the Kaplan–Meier method. Prognostic factors for patients with OTSCC were evaluated using the univariate log-rank test and a multivariate Cox proportional hazards model. ROC analysis revealed that the area under the curve was higher and more accurate for ΔSUVmax than for the other parameters. Additionally, patients with a ΔSUVmax ≥0.9 had significantly worse survival outcomes (28.9% vs 92.6%; p 18F-FDG PET may be an additional prognostic factor in OTSCC patients.
机译:本研究的目的是探讨双时点(DTP) 18 F-氟脱氧葡萄糖正电子发射断层显像( 18 F-FDG PET)的预后价值原发性口腔舌鳞状细胞癌(OTSCC)。该研究纳入了52位在术前两个小时即注射后1 h和2 h进行 18 F-FDG PET扫描的患者。计算了以下PET参数:两个时间点(SUV早期,SUV延迟)的最大标准化摄取值(SUVmax);保留指数(RI);和SUVmax增量(ΔSUVmax)。进行接收器工作特性(ROC)曲线分析以定义这些参数的最佳截止点。使用Kaplan-Meier方法计算总生存期。使用单变量对数秩检验和多元Cox比例风险模型评估OTSCC患者的预后因素。 ROC分析显示,ΔSUVmax的曲线下面积比其他参数更高且更准确。此外,ΔSUVmax≥0.9的患者的生存结局显着更差(28.9%比92.6%; p 18 FDG PET可能是OTSCC患者的另一个预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号